| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.003 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.089 | 0.003 |